Andreas H. Krieg

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Wolfram Trudo Knoefel · 4 shared papers, 2015–2022 · strength 0.49
   • Paper N, LNR or LODDS: Which Is the Most Appropriate Lymph Node Classification Scheme for Patients with Radically Resected Pa… DOI 10.3390/cancers14071834↗
   • Paper Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14143494↗
   • Paper Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival. DOI 10.1016/j.pan.2021.02.024↗
2. Tom Luedde · 3 shared papers, 2021–2024 · strength 0.49
   • Paper Elevated HbA1c Levels Are Associated with a Risk of Pancreatic Cancer: A Case-Control Study. DOI 10.3390/jcm13185584↗
   • Paper N, LNR or LODDS: Which Is the Most Appropriate Lymph Node Classification Scheme for Patients with Radically Resected Pa… DOI 10.3390/cancers14071834↗
   • Paper Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival. DOI 10.1016/j.pan.2021.02.024↗
3. Sami Alexander Safi · 3 shared papers, 2021–2022 · strength 0.42
   • Paper N, LNR or LODDS: Which Is the Most Appropriate Lymph Node Classification Scheme for Patients with Radically Resected Pa… DOI 10.3390/cancers14071834↗
   • Paper Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14143494↗
   • Paper Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival. DOI 10.1016/j.pan.2021.02.024↗
4. Iréne Esposito · 3 shared papers, 2021–2022 · strength 0.42
   • Paper N, LNR or LODDS: Which Is the Most Appropriate Lymph Node Classification Scheme for Patients with Radically Resected Pa… DOI 10.3390/cancers14071834↗
   • Paper Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14143494↗
   • Paper Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival. DOI 10.1016/j.pan.2021.02.024↗
5. Alexander Rehders · 2 shared papers, 2021–2022 · strength 0.27
   • Paper Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14143494↗
   • Paper Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival. DOI 10.1016/j.pan.2021.02.024↗
6. Lena Häberle · 2 shared papers, 2021–2022 · strength 0.27
   • Paper Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14143494↗
   • Paper Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival. DOI 10.1016/j.pan.2021.02.024↗
7. Steven Grewe · 1 shared paper, 2024 · strength 0.21
   • Paper Elevated HbA1c Levels Are Associated with a Risk of Pancreatic Cancer: A Case-Control Study. DOI 10.3390/jcm13185584↗
8. Karel Kostev · 1 shared paper, 2024 · strength 0.21
   • Paper Elevated HbA1c Levels Are Associated with a Risk of Pancreatic Cancer: A Case-Control Study. DOI 10.3390/jcm13185584↗
9. Christoph Roderburg · 1 shared paper, 2024 · strength 0.21
   • Paper Elevated HbA1c Levels Are Associated with a Risk of Pancreatic Cancer: A Case-Control Study. DOI 10.3390/jcm13185584↗
10. Dimitrios Prassas · 1 shared paper, 2022 · strength 0.15
    • Paper N, LNR or LODDS: Which Is the Most Appropriate Lymph Node Classification Scheme for Patients with Radically Resected Pa… DOI 10.3390/cancers14071834↗
11. Christian Vay · 1 shared paper, 2022 · strength 0.15
    • Paper Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14143494↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.